Suppression of IRS-1 expression by siRNA promotes apoptosis and renders ER+ breast carcinoma cells more sensitive to tamoxifen-stimulated cell death, whereas overexpression of IRS-1 confers resistance to TGF-β-induced cell death in hepatocellular carcinoma cells [73,74]. Here, ESR1 is linked to breast carcinoma.